Point72 (DIFC)’s Vigil Neuroscience VIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6
Closed -$47 1904
2025
Q2
$47 Sell
6
-1
-14% -$4 ﹤0.01% 1492
2025
Q1
$12 Hold
7
﹤0.01% 1616
2024
Q4
$12 Hold
7
﹤0.01% 1469
2024
Q3
$24 Sell
7
-5,499
-100% -$20.4K ﹤0.01% 1381
2024
Q2
$22K Buy
+5,506
New +$18.8K ﹤0.01% 1221

Other funds holding VIGL

Point72 (DIFC)'s VIGL Position: Q3 2025 in Review

Point72 (DIFC) sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 6 shares — an estimated $47 sold.

Point72 (DIFC) first reported a position in VIGL in Q2 2024 and held it in 5 quarters. The position peaked at $22K in Q2 2024. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

  • Point72 (DIFC) reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 6 Vigil Neuroscience shares in Q3 2025, an estimated $47.
  • Point72 (DIFC) first reported a position in Vigil Neuroscience in Q2 2024 and held it in 5 quarters.
  • Point72 (DIFC)'s Vigil Neuroscience position peaked at $22K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.